Robert Eisenbach

Of Counsel
Full contact info

For 30+ years I have been focused on getting results for clients by keeping an eye on the big picture, offering expertise and good judgment and keeping a cool head.

Experience

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Yinan Lin
Associate, Palo Alto
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Sirius Therapeutics Announces Collaboration With CRISPR Therapeutics

May 19, 2025

Cooley advised Sirius Therapeutics, a clinical-stage biotech company developing innovative small interfering RNA (siRNA) therapies for global markets, on its strategic partnership to develop and commercialize siRNA therapies with CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Navya Dasari
Associate, New York
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Santa Monica
Steve Przesmicki
Partner, San Diego
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
David Burns
Special Counsel, Washington, DC
Eileen Marshall
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado

Related Practices & Industries

Hengrui Pharmaceuticals Announces License Agreement With Merck KGaA

April 8, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck KGaA, Darmstadt, Germany for the commercialization in mainland China of SHR7280, an oral small-molecule gonadotropin-releasing hormone receptor antagonist, for indications including medical-assisted reproduction and gynecology.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Caroline Vu
Special Counsel, Palo Alto
Letian Wei
Legal Consultant, Shanghai
Marc Suskin
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Rebecca Ross
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Jiqiang Lin
Associate, New York
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Jiangsu Hengrui Pharmaceuticals Announces License Agreement With Merck

March 25, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck (NYSE: MRK), known as MSD outside of the US and Canada, for HRS-5346, an investigational oral small molecule lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a phase 2 clinical trial in China.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
David Burns
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Steve Przesmicki
Partner, San Diego

Related Practices & Industries

SKIMS Acquires SKKN by Kim From Kim Kardashian and Coty

March 21, 2025

Cooley advised Kim Kardashian, an American media personality, socialite and businesswoman, on SKIMS’ acquisition of SKKN by Kim, a beauty, skincare, and fragrance brand she founded, including the 20% stake held by Coty.

Read more

Related contacts

Dave Young
Partner, Santa Monica
Julia Kim
Special Counsel, New York
Kyle Hess
Associate, New York
Kathryn Benvenuti
Associate, New York
Mark Cikowski
Associate, Santa Monica
Adam Chase
Partner, Washington, DC
Kimberly Nguyen
Special Counsel, Reston
Liz Paisner
Associate, New York
Matthew Caplan
Partner, San Francisco
Stephanie Gentile
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Calvin Lee
Associate, New York
John Paul Oleksiuk
Partner, New York
Ross Eberly
Partner, Santa Monica
Austin Holt
Partner, Santa Monica
Bram G. Couvreur
Partner, Santa Monica
Michael Klein
Partner, New York
Michael Neumeister
Partner, Los Angeles
Robert Eisenbach
Of Counsel, San Francisco
Jessica Girone
Associate, Santa Monica

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

Northern California Super Lawyers

Best Lawyers in America

Memberships and affiliations

American Bankruptcy Institute, member

American Bar Association (ABA)

Bay Area Bankruptcy Forum

Turnaround Management Association

The best in the business

Legal 500 US